Namir Shaabani
0000-0003-3548-5899
Scripps Research Institute
5 papers found
Refreshing results…
Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology
The probacterial effect of type I interferon signaling requires its own negative regulator USP18
Missing publications? Search for publications with a matching author name.